Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charis Eng

Showing results (171-180 of 555) with videos related to

Pageof 56
Sort By:
Melanoma Research|May 30, 2009
Nuclear PTEN levels and G2 progression in melanoma cellsAbraham I Jacob, Todd Romigh, Kristin A Waite, et al.
BMC Bioinformatics|March 16, 2019
Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma riskVisanu Wanchai, Jing Jin, Emine Bircan, et al.
Cell Reports. Medicine|January 19, 2024
Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndromeDarren Liu, Lamis Yehia, Andrew Dhawan, et al.
Endocrine-Related Cancer|December 14, 2017
The microbiome in <i>PTEN</i> hamartoma tumor syndromeVictoria Byrd, Ted Getz, Roshan Padmanabhan, et al.
Translational Psychiatry|January 22, 2019
Constitutional mislocalization of Pten drives precocious maturation in oligodendrocytes and aberrant myelination in model of autism spectrum disorderHyunpil Lee, Stetson Thacker, Nicholas Sarn, et al.
Human Molecular Genetics|October 8, 2010
Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53Xin He, Ying Ni, Yu Wang, et al.
Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.
Journal of Personalized Medicine|January 8, 2015
Formative evaluation of clinician experience with integrating family history-based clinical decision support into clinical practiceMegan Doerr, Emily Edelman, Emily Gabitzsch, et al.
JAMA|May 18, 2007
Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinomaKoichi Fukino, Lei Shen, Attila Patocs, et al.
Plos Genetics|May 9, 2009
Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genesYongzhong Zhao, Michael Marotta, Evan E Eichler, et al.
Pageof 56

Showing results (171-180 of 555) with videos related to

Sort By:
Pageof 56
Melanoma Research|May 30, 2009
Nuclear PTEN levels and G2 progression in melanoma cellsAbraham I Jacob, Todd Romigh, Kristin A Waite, et al.
BMC Bioinformatics|March 16, 2019
Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma riskVisanu Wanchai, Jing Jin, Emine Bircan, et al.
Cell Reports. Medicine|January 19, 2024
Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndromeDarren Liu, Lamis Yehia, Andrew Dhawan, et al.
Endocrine-Related Cancer|December 14, 2017
The microbiome in <i>PTEN</i> hamartoma tumor syndromeVictoria Byrd, Ted Getz, Roshan Padmanabhan, et al.
Translational Psychiatry|January 22, 2019
Constitutional mislocalization of Pten drives precocious maturation in oligodendrocytes and aberrant myelination in model of autism spectrum disorderHyunpil Lee, Stetson Thacker, Nicholas Sarn, et al.
Human Molecular Genetics|October 8, 2010
Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53Xin He, Ying Ni, Yu Wang, et al.
Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.
Journal of Personalized Medicine|January 8, 2015
Formative evaluation of clinician experience with integrating family history-based clinical decision support into clinical practiceMegan Doerr, Emily Edelman, Emily Gabitzsch, et al.
JAMA|May 18, 2007
Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinomaKoichi Fukino, Lei Shen, Attila Patocs, et al.
Plos Genetics|May 9, 2009
Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genesYongzhong Zhao, Michael Marotta, Evan E Eichler, et al.
Pageof 56